Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

キッセイ薬品工業

栄研化学

Taisei Lamick

TORII PHARMACEUTICAL

JAPAN PURE CHEMICAL

NITTO FC

関西ペイント

SAWAI PHARMACEUTICAL

富士製薬工業

TAIKO PHARMACEUTICAL

ONO PHARMACEUTICAL

Aica Kogyo

SEIKAGAKU　

NIPPON KAYAKU

ROHTO PHARMACEUTICAL

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

Nittetsu Mining

PIONEER

クラリオン

クラリオン

クラリオン

Financial Indicator Details: 千寿製薬 (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: 千寿製薬 (Annual )

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	- (-0.50%)	5.07% (1.53%)	7.43% (-1.67%)	8.83% (3.05%)
C/F margin (Industry Average)	- (8.51%)	9.65% (7.04%)	19.75% (6.35%)	25.82% (8.25%)
ROA (Industry Average)	- (1.04%)	3.44% (2.07%)	5.10% (0.06%)	6.09% (2.71%)
ROE (Industry Average)	- (0.03%)	4.99% (2.96%)	7.12% (4.68%)	8.65% (4.57%)
Growth	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (5.01%)	3.31% (2.61%)	8.96% (-0.40%)	11.66% (8.16%)
Sales growth (Industry Average)	- (-2.67%)	- (-)	6.02% (1.07%)	14.25% (2.24%)
Net profit growth (Industry Average)	- (203.46%)	- (63.25%)	55.32% (3.89%)	35.66% (90.38%)
Operating C/F growth (Industry Average)	- (275.10%)	- (35.09%)	116.88% (-6.09%)	49.34% (138.39%)
Stability	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	- (54.51%)	68.87% (55.00%)	71.70% (53.59%)	70.41% (56.30%)
Liquidity ratio (Industry Average)	- (225.70%)	238.52% (237.55%)	267.15% (239.89%)	214.96% (236.21%)
C/F ratio current liabilities (Industry Average)	- (303.31%)	336.04% (434.79%)	146.73% (929.73%)	128.79% (573.30%)
Quick ratio (Industry Average)	- (148.85%)	141.62% (156.17%)	185.52% (160.84%)	156.74% (156.81%)
Turnover	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	- (94.27day)	95.40day (93.96day)	102.32day (97.92day)	88.51day (98.27day)
Inventory turnover (Industry Average)	- (52.58day)	51.83day (52.64day)	55.29day (56.59day)	42.11day (58.68day)
Payable turnover (Industry Average)	- (49.82day)	34.36day (49.52day)	39.03day (52.10day)	32.18day (51.12day)
Working capita turnover (Industry Average)	- (97.02day)	112.87day (97.08day)	118.58day (102.41day)	98.44day (105.83day)
Stock etc.	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (34.57%)	- (1.49%)	- (-3.85%)	- (21.16%)
Dividend Yield (Industry Average)	- (1.93%)	- (2.17%)	- (2.45%)	- (2.07%)
PER (Industry Average)	- (23.06%)	- (16.22%)	- (29.19%)	- (16.58%)
PBR (Industry Average)	- (1.06%)	- (1.04%)	- (0.95%)	- (1.08%)
PCFR (Industry Average)	- (9.23%)	- (-2.43%)	- (9.50%)	- (7.56%)
PSR (Industry Average)	- (0.88%)	- (1.10%)	- (0.90%)	- (1.01%)

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	5.36% (-27.66%)	2.67% (-4.34%)	5.42% (-5.37%)	7.90% (-10.69%)	9.38% (8.92%)
C/F margin (Industry Average)	5.02% (0.87%)	8.11% (1.04%)	- (0.82%)	- (-0.81%)	- (-39.63%)
ROA (Industry Average)	3.35% (0.52%)	1.75% (0.92%)	3.66% (1.42%)	5.38% (-0.27%)	6.42% (1.53%)
ROE (Industry Average)	4.94% (-0.84%)	2.45% (-0.46%)	5.30% (1.81%)	7.48% (3.42%)	9.09% (2.62%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	2.06% (3.64%)	4.14% (3.03%)	9.39% (0.04%)	11.61% (3.91%)
Sales growth (Industry Average)	- (-)	1.37% (-3.48%)	10.99% (6.70%)	6.02% (0.75%)	14.25% (-1.74%)
Net profit growth (Industry Average)	- (-)	-49.42% (166.48%)	125.11% (43.48%)	54.48% (-47.04%)	35.63% (62.14%)
Operating C/F growth (Industry Average)	- (-)	63.89% (89.80%)	- (77.44%)	- (-44.41%)	- (46.89%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	67.80% (56.79%)	71.60% (57.65%)	69.04% (57.17%)	71.96% (55.93%)	70.65% (57.57%)
Liquidity ratio (Industry Average)	226.63% (337.22%)	263.01% (276.75%)	234.30% (266.94%)	264.55% (314.47%)	207.30% (233.84%)
C/F ratio current liabilities (Industry Average)	681.90% (48.90%)	312.07% (53.10%)	- (31.35%)	- (76.77%)	- (31.87%)
Quick ratio (Industry Average)	163.31% (167.28%)	165.60% (183.78%)	137.41% (174.83%)	182.97% (228.06%)	149.11% (169.77%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	90.90day (87.55day)	88.21day (98.39day)	95.40day (95.88day)	102.32day (98.58day)	88.51day (67.18day)
Inventory turnover (Industry Average)	38.07day (50.17day)	49.64day (48.43day)	51.83day (47.43day)	55.29day (50.67day)	42.11day (38.21day)
Payable turnover (Industry Average)	39.97day (45.70day)	41.42day (51.63day)	34.36day (51.13day)	39.03day (53.57day)	32.16day (34.24day)
Working capita turnover (Industry Average)	89.00day (92.02day)	96.43day (95.19day)	112.87day (92.19day)	118.58day (95.69day)	98.47day (71.15day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	- (34.46%)	- (3.11%)	- (-3.30%)	- (24.19%)
Dividend Yield (Industry Average)	- (0.15%)	- (0.09%)	- (0.10%)	- (0.16%)	- (0.15%)
PER (Industry Average)	- (34.12%)	- (27.80%)	- (13.58%)	- (22.26%)	- (26.42%)
PBR (Industry Average)	- (0.97%)	- (1.21%)	- (1.17%)	- (1.08%)	- (1.54%)
PCFR (Industry Average)	- (0.27%)	- (0.62%)	- (0.23%)	- (0.08%)	- (4.97%)
PSR (Industry Average)	- (3.42%)	- (4.34%)	- (3.67%)	- (4.37%)	- (10.14%)

Financial Indicator Details: 千寿製薬

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	-	5.07%	7.43%	8.83%
C/F margin	-	9.65%	19.75%	25.82%
ROA	-	3.44%	5.10%	6.09%
ROE	-	4.99%	7.12%	8.65%
Recurring margin	-	12.66%	17.18%	8.65%
EBIT margin	-	8.79%	12.58%	13.94%
EBITDA margin	-	18.30%	21.19%	21.26%
NOPAT margin	-	5.27%	7.54%	8.36%
Sales SG rates	-	34.69%	35.29%	34.88%
Sales SG&A rates	-	63.80%	60.21%	63.63%
Sales R&D expenses rates	-	-	-	-
Sales depreciation rates	-	9.50%	8.61%	7.32%
Capital expenditures net sales ratio	-	-2.81%	-5.73%	-9.00%
Indicator	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	-	37.71%	23.70%
Equity growth	-	3.31%	8.96%	11.66%
Total assets growth	-	-	4.65%	13.72%
Sales growth	-	-	6.02%	14.25%
Net profit growth	-	-	55.32%	35.66%
Operating C/F growth	-	-	116.88%	49.34%
Recurring profit growth	-	-	43.90%	-42.46%
EBIT growth	-	-	51.56%	26.62%
EBITDA growth	-	-	22.74%	14.64%
NOPAT growth	-	-	51.56%	26.62%
Operating expenses growth	-	-	-	-
Indicator	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	-	68.87%	71.70%	70.41%
Liquidity ratio	-	238.52%	267.15%	214.96%
C/F ratio current liabilities	-	336.04%	146.73%	128.79%
Quick ratio	-	141.62%	185.52%	156.74%
Fixed ratio	-	35.92%	32.83%	33.99%
D/E ratio	-	4.98%	-	-
Loan to Value Ratio	-	3.43%	-	-
Business investment C/F ratio	-	-29.15%	-29.05%	-34.88%
Liabilities with interest growth	-	-	-100.00%	-
Indicator	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	-	72.34day	93.97day	101.75day
Receivables turnover	-	95.40day	102.32day	88.51day
Inventory turnover	-	51.83day	55.29day	42.11day
Fixed assets turnover	-	133.21day	125.12day	126.60day
Total asset turnover	-	538.35day	531.41day	528.95day
Payable turnover	-	34.36day	39.03day	32.18day
Capital turnover	-	21.81day	20.57day	18.01day
Equity turnover	-	370.77day	381.06day	372.44day
Working capita turnover	-	112.87day	118.58day	98.44day
Indicator	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	-	¥ 4 B	¥ 6 B	¥ 7 B
Accounts receivable-trade	-	¥ 6 B	¥ 7 B	¥ 6 B
Other Current Assets	-	¥ 13 B	¥ 12 B	¥ 12 B
Current Assets	-	¥ 18 B	¥ 19 B	¥ 20 B
Tangible Assets	-	¥ 8 B	¥ 8 B	¥ 9 B
Intangible Assets	-	¥ 2 B	¥ 3 B	¥ 4 B
Investment etc.	-	¥ 4 B	¥ 5 B	¥ 7 B
Total Assets	-	¥ 34 B	¥ 36 B	¥ 41 B
Current Liabilities	¥ -23 B	¥ 7 B	¥ 7 B	¥ 9 B
Fixed Liabilities	-	¥ 3 B	¥ 3 B	¥ 2 B
Liabilities with interest	-	¥ 1 B	-	-
Net Assets	¥ 23 B	¥ 24 B	¥ 26 B	¥ 29 B
Capital stock	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Capital surplus etc.	¥ 21 B	¥ 22 B	¥ 24 B	¥ 27 B
Liabilities and net assets	-	¥ 34 B	¥ 36 B	¥ 41 B
Indicator	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	-	¥ 23 B	¥ 25 B	¥ 28 B
Cost of Sales	-	¥ 8 B	¥ 8 B	¥ 10 B
Gross profit	-	¥ 15 B	¥ 16 B	¥ 18 B
Other income	-	¥ 3 B	¥ 3 B	¥ 4 B
SG&A	-	¥ 15 B	¥ 15 B	¥ 18 B
Other expenses	-	¥ 3 B	¥ 2 B	¥ 2 B
Net income	-	¥ 1 B	¥ 1 B	¥ 2 B
Operating income	-	¥ 356 M	¥ 1 B	¥ 423 M
Ordinary Income	-	¥ 2 B	¥ 4 B	¥ 2 B
EBITDA	-	¥ 4 B	¥ 5 B	¥ 6 B
Income before income taxes	-	¥ 2 B	¥ 3 B	¥ 4 B
Depreciation	-	¥ 2 B	¥ 2 B	¥ 2 B
R&D expenses	-	-	-	-
Income taxes	-	¥ 878 M	¥ 1 B	¥ 1 B
Indicator	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	-	¥ 2 B	¥ 4 B	¥ 7 B
Investment CF	-	¥ -1 B	¥ -624 M	¥ -4 B
Financial CF	-	¥ -265 M	¥ -1 B	¥ -164 M
Foreign Exchange Effects	-	¥ 58 M	¥ -3 M	¥ -1 B
Net Change in Cash	-	¥ 972 M	¥ 2 B	¥ 1 B
Free CF	-	¥ 1 B	¥ 4 B	¥ 3 B
Capital expenditures	-	¥ -666 M	¥ -1 B	¥ -2 B
Cash dividends paid	-	¥ -126 M	¥ -126 M	¥ -126 M
Repayment loans	-	¥ -100 M	¥ -1 B	-
Indicator	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-
Dividends from surplus	-	¥ -126 M	¥ -126 M	¥ -126 M
Net income	-	¥ 1 B	¥ 1 B	¥ 2 B
Purchase of treasury stock	-	-	-	-
Other Change in Stockholders Equity	-	¥ -68 M	-	¥ 1 K
Other Change in Net Assets	-	¥ -234 M	¥ 414 M	¥ 651 M
Net Change in Net Assets	-	¥ 772 M	¥ 2 B	¥ 3 B

Financial Indicator Details: 千寿製薬

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	5.36%	2.67%	5.42%	7.90%	9.38%
C/F margin	5.02%	8.11%	-	-	-
ROA	3.35%	1.75%	3.66%	5.38%	6.42%
ROE	4.94%	2.45%	5.30%	7.48%	9.09%
Recurring margin	9.86%	3.95%	13.01%	17.65%	9.21%
EBIT margin	9.50%	4.91%	9.15%	13.05%	14.50%
EBITDA margin	12.51%	9.40%	9.15%	13.05%	14.50%
NOPAT margin	5.70%	2.95%	5.49%	7.83%	8.70%
Sales SG rates	33.39%	33.82%	34.66%	35.22%	34.90%
Sales SG&A rates	66.13%	72.59%	63.44%	59.74%	63.07%
Sales R&D expenses rates	-	-	-	-	-
Sales depreciation rates	3.00%	4.48%	-	-	-
Capital expenditures net sales ratio	-14.84%	-10.93%	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	-41.85%	15.18%	43.33%	15.98%
Equity growth	-	2.06%	4.14%	9.39%	11.61%
Total assets growth	-	-3.33%	8.01%	4.95%	13.68%
Sales growth	-	1.37%	10.99%	6.02%	14.25%
Net profit growth	-	-49.42%	125.11%	54.48%	35.63%
Operating C/F growth	-	63.89%	-	-	-
Recurring profit growth	-	-59.30%	264.80%	43.85%	-40.40%
EBIT growth	-	-47.54%	106.54%	51.20%	26.93%
EBITDA growth	-	-23.82%	8.03%	51.20%	26.93%
NOPAT growth	-	-47.54%	106.54%	51.20%	26.93%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	67.80%	71.60%	69.04%	71.96%	70.65%
Liquidity ratio	226.63%	263.01%	234.30%	264.55%	207.30%
C/F ratio current liabilities	681.90%	312.07%	-	-	-
Quick ratio	163.31%	165.60%	137.41%	182.97%	149.11%
Fixed ratio	45.84%	42.98%	35.61%	32.42%	33.59%
D/E ratio	6.13%	5.58%	4.94%	-	-
Loan to Value Ratio	4.16%	3.99%	3.41%	-	-
Business investment C/F ratio	-295.59%	-134.70%	-	-	-
Liabilities with interest growth	-	-7.14%	-7.69%	-100.00%	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	113.18day	64.92day	67.37day	91.08day	92.47day
Receivables turnover	90.90day	88.21day	95.40day	102.32day	88.51day
Inventory turnover	38.07day	49.64day	51.83day	55.29day	42.11day
Fixed assets turnover	181.34day	171.21day	133.11day	125.03day	126.56day
Total asset turnover	583.40day	556.29day	541.33day	535.88day	533.23day
Payable turnover	39.97day	41.42day	34.36day	39.03day	32.16day
Capital turnover	24.54day	24.21day	21.81day	20.57day	18.01day
Equity turnover	395.59day	398.32day	373.74day	385.63day	376.74day
Working capita turnover	89.00day	96.43day	112.87day	118.58day	98.47day
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 6 B	¥ 3 B	¥ 4 B	¥ 6 B	¥ 7 B
Accounts receivable-trade	¥ 5 B	¥ 5 B	¥ 6 B	¥ 7 B	¥ 6 B
Other Current Assets	¥ 9 B	¥ 10 B	¥ 13 B	¥ 12 B	¥ 12 B
Current Assets	¥ 16 B	¥ 14 B	¥ 18 B	¥ 19 B	¥ 19 B
Tangible Assets	¥ 10 B	¥ 10 B	¥ 8 B	¥ 8 B	¥ 9 B
Intangible Assets	¥ 1 B	¥ 2 B	¥ 2 B	¥ 3 B	¥ 4 B
Investment etc.	¥ 5 B	¥ 5 B	¥ 5 B	¥ 5 B	¥ 8 B
Total Assets	¥ 33 B	¥ 32 B	¥ 35 B	¥ 36 B	¥ 41 B
Current Liabilities	¥ 7 B	¥ 5 B	¥ 7 B	¥ 7 B	¥ 9 B
Fixed Liabilities	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 2 B
Liabilities with interest	¥ 1 B	¥ 1 B	¥ 1 B	-	-
Net Assets	¥ 22 B	¥ 23 B	¥ 24 B	¥ 26 B	¥ 29 B
Capital stock	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Capital surplus etc.	¥ 21 B	¥ 21 B	¥ 22 B	¥ 25 B	¥ 28 B
Liabilities and net assets	¥ 33 B	¥ 32 B	¥ 35 B	¥ 36 B	¥ 41 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 21 B	¥ 21 B	¥ 23 B	¥ 25 B	¥ 28 B
Cost of Sales	¥ 7 B	¥ 7 B	¥ 8 B	¥ 8 B	¥ 10 B
Gross profit	¥ 14 B	¥ 14 B	¥ 15 B	¥ 16 B	¥ 18 B
Other income	¥ 2 B	¥ 2 B	¥ 3 B	¥ 3 B	¥ 4 B
SG&A	¥ 13 B	¥ 15 B	¥ 15 B	¥ 14 B	¥ 18 B
Other expenses	¥ 1 B	¥ 870 M	¥ 3 B	¥ 2 B	¥ 2 B
Net income	¥ 1 B	¥ 571 M	¥ 1 B	¥ 1 B	¥ 2 B
Operating income	¥ 99 M	¥ -1 B	¥ 439 M	¥ 1 B	¥ 584 M
Ordinary Income	¥ 2 B	¥ 844 M	¥ 3 B	¥ 4 B	¥ 2 B
EBITDA	¥ 2 B	¥ 2 B	¥ 2 B	¥ 3 B	¥ 4 B
Income before income taxes	¥ 2 B	¥ 1 B	¥ 2 B	¥ 3 B	¥ 4 B
Depreciation	¥ 633 M	¥ 956 M	-	-	-
R&D expenses	-	-	-	-	-
Income taxes	¥ 886 M	¥ 476 M	¥ 878 M	¥ 1 B	¥ 1 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	¥ 1 B	¥ 1 B	-	-	-
Investment CF	¥ -1 B	¥ -2 B	-	-	-
Financial CF	¥ -155 M	¥ -240 M	-	-	-
Foreign Exchange Effects	¥ 515 K	¥ 2 M	-	-	-
Net Change in Cash	¥ -596 M	¥ -528 M	-	-	-
Free CF	¥ -441 M	¥ -291 M	-	-	-
Capital expenditures	¥ -3 B	¥ -2 B	-	-	-
Cash dividends paid	¥ -126 M	¥ -126 M	-	-	-
Repayment loans	¥ -25 M	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -126 M	¥ -126 M	¥ -126 M	¥ -126 M	¥ -126 M
Net income	¥ 1 B	¥ 571 M	¥ 1 B	¥ 1 B	¥ 2 B
Purchase of treasury stock	-	-	-	-	-
Other Change in Stockholders Equity	-	-	¥ -1 K	¥ 1 K	-
Other Change in Net Assets	¥ -550 M	¥ 27 M	¥ -193 M	¥ 418 M	¥ 515 M
Net Change in Net Assets	¥ 452 M	¥ 472 M	¥ 965 M	¥ 2 B	¥ 3 B

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: 千寿製薬 (Annual )

Statement Type

Annual : 千寿製薬

Second quarter : 千寿製薬

Analysis Menu

Outline : 千寿製薬

Statement : 千寿製薬

Rating : 千寿製薬

Indicator : 千寿製薬

Download : 千寿製薬

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Osaka - EDIUNET Prefectures

Osaka大阪市 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
千寿製薬			Chemicals	3	Annual	A

Related Company

参天製薬 (Sales ¥ 106 B)

富士製薬工業 (Sales ¥ 23 B)

JSR (Sales ¥ 258 B)

Milbon (Sales ¥ 23 B)

KUREHA (Sales ¥ 73 B)

MANDOM (Sales ¥ 40 B)

KUMIAI CHEMICAL INDUSTRY (Sales ¥ 42 B)

関西ペイント (Sales ¥ 138 B)

長谷川香料 (Sales ¥ 37 B)

ONO PHARMACEUTICAL (Sales ¥ 143 B)

NIPPON KAYAKU (Sales ¥ 84 B)

NITTO FC (Sales ¥ 12 B)

SAWAI PHARMACEUTICAL (Sales ¥ 79 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .